Document:

Exhibit 10.29

 

 

NOTICE OF CONVERSION The undersigned hereby elects to convert
their May 3, 2018 Convertible Promissory Note entered into with Electromedical Technologies, Inc., a Delaware corporation (the
 "Issuer"), in the principal amount of $25 ,000 of principal plus accrued interest of $2,947.75 totaling $27,947.75 into
39,363 shares of the Issuer's restricted Common Stock at the rate of$0. 71 per share according to the terms of the Note. No fee
will be charged to the Holder for any conversion, except for transfer taxes, if any. BEN HOWDEN Date: October 24, 2019 CAROL HOWDEN
Date: October 24, 2019 AGREED TO BY: ELECTROMEDICAL TECHNOLOGIES, INC. By: Matthew Wolfson, CEOExhibit 10.30

 

 

ACCREDITED SUBSCRIPTION AGREEMENT This Accredited Subscription
Agreement ("Agreement”) is entered into as of the 31 day of October 2018 by and between Electromedical Technologies,
Inc., a Delaware corporation (the "Company"), and the undersigned investor, Gene Taubman, (the "Investor").
If more than one person signs this Agreement as an investor, then all references to Investor in this Agreement include the co-investor(s),
jointly and severally. 1. Subscription. Investor hereby irrevocably subscribes for 100,000 shares of the Company's common stock
(the "Shares") at a price of$1.00 per share for a total purchase price of $100,000.00, subject to acceptance by the
Company. 2. Approval and Acceptance. The effectiveness of this Agreement is subject to acceptance by the Company by signing below
where indicated. If this Agreement is not approved and accepted, then the Company will notify Investor and return any funds Investor
may have delivered to the Company promptly after non-acceptance. 3. Disclosure. Investor acknowledges the following: The Company
has made available to Investor, or to Investor's attorney, accountant or representative, all documents that Investor has requested;
Investor has requested all documents and other information that Investor has deemed necessary or appropriate for purposes of evaluating
a potential investment in the Company and purchasing the Shares; The Company has provided satisfactory answers to all questions
concerning the potential investment in the Company; Investor has carefully considered and has, to the extent Investor believes
such discussion necessary, discussed with Investor's professional legal, tax and financial advisers the suitability of an investment
in the Company for Investor's particular tax and financial situation. 4. Investor has read all of the Company's filings on the
SEC's Edgar web cite and the Investor acknowledges that he fully understands all the disclosures including the Company's business
plan in those filings. RISK FACTORS An investment in the securities offered hereby involves a high degree of risk and is highly
speculative in nature. You should consider, amongst others, the following risk factors prior to making your Investment. The discussion
below highlights some of the more important risks regarding the Company and the Investment. The risks highlighted below should
not be assumed to be the only factors that could affect future performance. In addition, other written or oral statements, which
constitute forward-looking statements, may be made by or on behalf of the Company. Words such as "expects," "anticipates,"
 "intends," "plans," "believes," "seeks," "estimates," or variations of such
words and similar expressions are intended to identify such Page 1 of 10

    	 

     

    

 

 

SIGNATURE PAGE TO ELECTROMEDICAL TECHNOLOGIES, INC. SUBSCRIPTION
AGREEMENT PRINT OR TYPE NAME OF INVESTOR And title if not an individual Signature Date: Oct. 31, 2018 Address: SS or EIN# ACCEPTANCE
OF SUBSCRIPTION This Subscription Agreement has been approved by the Company and is accepted as Of October __, 2018. By: Name:
Matthew Wolfson Title: CEO Page 8 of 10

    	 

     

    

 

 

ACCREDITATION The undersigned represents and warrants that the
he/she/it is an Accredited Investor pursuant to one or more of the following categories (initial applicable categories and sign
below): a. A natural person (i.e., not an entity) whose individual net worth or joint net worth with spouse at the time of purchase,
excluding homes, home furnishings and automobiles, and reflecting a deduction of all current debts and obligations to pay money,
including but not limited to home mortgage debt, exceeds $1,000,000. b. A natural person (i.e., not an entity) who had an individual
income in excess of $200,000 in each of the two most recent years or joint income with spouse in excess of $300,000 in each of
those years and has a reasonable expectation of reaching the same level of income in the current year. ___ c. Any organization
described in Section 501(c)(3) of the Internal Revenue Code, or any corporation, limited liability the Company, Massachusetts
or similar business trust or partnership, not formed for the specific purpose of acquiring the securities offered, with total
assets in excess of $5,000,000. ___ d. A private business development company (as defined in Section 202(a)(22) of the Investment
Advisers Act of 1940). ___ e. Any bank as defined in Section 3(a)(2) of the Securities Act of 1933, as amended (the "Act"),
or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Act whether acting in its individual
or fiduciary capacity; any broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934; any insurance
the Company as defined in Section 2(13) of the Act; any investment the Company registered under the Investment Company Act of
1940 (the "1 940 Act") or a business development the Company as defined in Section 2(a)( 48) of the 1940 Act~ any Small
Business Investment The Company licensed by the U.S. Small Business Administration under Section 30l(c) or (d) of the Small Business
Investment Act of 1958; any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality
of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;
or any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision
is made by a plan fiduciary, as defined in Section 3(21) of such act which is either a bank, savings and loan association, insurance
the Company, or registered investment advisor, or if the employee benefit plan has total assets in excess of $5,000,000 or, if
a self directed plan, with investment decisions made solely by persons that are accredited Investors. f. Any trust with total
assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed
by a Page 9 of 10

    	 

     

    

 

 

sophisticated person. For purposes of this exemption, a sophisticated
person is one who has such knowledge and experience in financial and business matters that such person is capable of evaluating
the merits and risks of the prospective investment. ____ g. Any entity in which all the equity owners are accredited investors
under the above subsections. Date: 10/31/18 Print Name Gene Taubman Signature (if not individual, add title) Page 10 of 10Exhibit 10.31

 

 

CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES,
INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation,
(the "Company"), hereby unanimously consents to the following actions taken by the Company on October 31, 2018. RESOLVED:
To accept the Accredited Subscription Agreement from Gene Taubman. RESOLVED: Pursuant to the Accredited Subscription Agreement,
to issue 100,000 shares of the Company's restricted common stock to Gene Taubman Therapies, Inc. at the price of $1.00 per share
for a total consideration of $100,000. RESOLVED: That Pacific Stock Transfer is hereby instructed to issue 100,000 shares of the
Company's restricted common stock to Gene Taubman. There being no further business requiring board action or consideration, on
motion duly made, and carried, the meeting was adjourned.Exhibit 10.32

 

 

Consulting Agreement This consulting agreement (the "Agreement")
is made and entered on this day 11th day of February (the "Effective Date") by and between Robert L. Hymers III (hereinafter
referred to as the "Consultant") and Electromedical Technologies, Inc. (hereinafter referred to as the "Client").
1. Services The Consultant will provide strategic business and business services to the Client, which may include: • Financial
Consulting assistance with review of quarterly and annual filings with OTC Markets and/or the SEC. • Corporate Governance
and Compliance • Communication, review and coordination of document transfers to auditors and attorneys. • Assistance
with negotiation with contracts, financings, contracts and review and drafting of corresponding agreements, all of which must
be pre-approved by the Client's legal counsel. • Communication with SEC attorney, auditors and outside accountants to complete
resolutions and regulatory filings The scope of services will be subject to change from time to time as agreed to between the
Consultant and the Client. The Consultant will also provide briefings, updates and other forms of communication to keep the Client
informed regarding the progress of the work. The services will be rendered from the Consultant's location and/or the Client's
location subject to change as necessary to properly service the Client. The Consultant will perform the services in a competent
and professional manner. The Consultant will comply with applicable laws. The Consultant shall be responsible for all taxes on
any compensation. 2. Compensation and Reimbursement of Expenses The Client agrees to pay the Consultant a fixed fee of one hundred
fifty thousand (150,000) restricted common shares for the services provided. This fee shall cover 12 months of services pursuant
to Section 3 of this Agreement. The total amount owed per this agreement shall be deemed earned in full upon the execution of
this agreement (i.e., February I 2, 20 19) and shall not vest over time. For purposes of this agreement, the shares are valued
at $1.00 per share. The Consultant will maintain adequate documentation and records to support all costs invoiced to the Client
including receipts for travel related expenses however, such expenses

    	 

     

    

 

 

must be approved by the Client prior to being incurred by Consultant.
Payments made by the Client to the Consultant will not deduct any taxes and the Client will provide the Consultant with IRS Form
I 099 at the end of each calendar year. For purposes of issuing IRS Form I 099, the Consultant will provide a social security
number upon execution of his agreement. The shares of Common Stock provided for a compensation to Consultant may not be sold or
transferred unless: (i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the Consultant
or its transfer agent shall have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope
customary for opinions of counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold
or transferred pursuant to an exemption from such registration (iii) such shares are sold or transferred pursuant to Rule I44
under the Act (or a successor rule) ("Rule I44"). The certificate for shares of Common Stock has not been so included
in an effective registration statement or that has not been sold pursuant to an effective registration statement or an exemption
that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate: "NEITHER THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF I933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES." 3. Term and Termination This agreement will commence on
the effective date set forth and continue for a period of twelve months from the effective date unless terminated earlier. Either
party may terminate this agreement at any time upon thirty-day (30) notification. The Client may at its option agree to renew,
extend and revise this agreement prior to its expiration.

    	 

     

    

 

 

4. Confidential Information Both parties acknowledge that there
is an exchange of confidential and proprietary information associated with this agreement. Confidential and proprietary information
may include documents, communications, plans, processes, formulations, data, know-how, financial information, techniques, methods,
customers, suppliers, partners, patents, trademarks, designs, and other forms of tangible or intangible artifacts owned by the
Client. Confidential and proprietary information does not include information within the public domain, information that has been
publicly known prior to the execution of this agreement, or information that the Consultant developed independent of any confidential
information. The Consultant will not divulge, disseminate, publish or otherwise disclose any information without the prior consent
of the Client. The Consultant will not use any information for purposes other than the performance of services described in this
agreement. The Client agrees to not disclose confidential information to the Consultant except to the extent that the Consultant
requires this information to fulfill the obligations within this agreement. If the Client has any concerns over the sharing of
sensitive information and requires additional control measures, the Consultant will establish secured means of information sharing
that are mutually agreeable to both parties. These control measures may include restricting who can copy, print, or change documents
during the course of the engagement. 5. Indemnification Not withstanding other provisions of this agreement, the Client shall
indemnify, defend and hold harmless the Consultant against claims, liabilities, damages, losses or other obligations, which may
arise from this agreement. 6. Relationship of Parties The parties agree that this agreement creates an independent contractor
relationship, not an employment relationship. Neither party is, nor shall claim to be, a legal agent, representative, partner,
or employee of the other, and neither shall have the right or authority to contract in the name of the other, nor shall it assume
or create any obligations, debts, accounts or liabilities for the other. 7. Role of the Consultant The Consultant will not make
management decisions on behalf of the Client. The role of the Consultant shall be advisory in nature with no perceived conflicts
of interest prior to, during or after the engagement with the Client. This role will also extend to any third parties that the
Consultant may use during the course of the engagement.

    	 

     

    

 

 

8. Reliance on Client Provide Information Regarding any information
or material that the Company furnishes to Consultant or any other entity in connection with this Agreement, the Company acknowledges
and confirms that (i) Consultant will use and rely on such information and material without independently verifying the same,
(ii) Consultant does not assume responsibility for the accuracy or completeness of any of the information or material, (iii) Consultant
will not make any appraisal, evaluation or independent determination regarding such information or material or the Company and
(iv) Consultants shall not have any liability in connection with such information or material. The Company represents to Consultant
that the information and material to be furnished by the Company, when delivered, will be true, complete and correct in all material
respects and will not contain any material misstatement of fact or omit to state any material fact necessary to make the statements
contained therein not misleading. The Company shall promptly notify Consultants if it learns of any material inaccuracy or misstatement
in, or material omission from, any information or material delivered to Consultant. 9. Quality Assurance and Control In an effort
to ensure that the Consultant provides high quality work, the Client will assign the CEO of the Client company to review and approve
the work of the Consultant. In the event that the Consultant uses a third party, the Consultant is responsible for the quality
of the work delivered by the third party. 10. Non-Agent of Client It is understood that Consultant is not acting as agent or fiduciary
of, and have no liabilities to, the equity holders of the Company or any other third party in connection with this Agreement or
any introductions, services or transactions hereunder, all of which liabilities are expressly waived. 11. Clawback The compensation
granted under this agreement are subject to the terms of the client's recoupment, clawback or similar policy as it may be in effect
from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances (e.g. failure
to perform throughout the term, gross negligence, violation of State laws, violation of SEC regulations) require repayment or
forfeiture of compensation or any shares of Common Stock or other cash or property received. 12. Governing Law This Agreement
shall be governed by and interpreted in accordance with the laws of the state of Arizona applicable to agreements negotiated,
executed and to be performed in the

    	 

     

    

 

 

state, without regard to the choice or conflicts of law rules or
principles of that state. The parties hereto hereby consent to the jurisdiction of the state courts located in Scottdale, Arizona,
over the parties and any disputes, claims, actions, suits and proceeding relating to this agreement or the transactions contemplated
herein. 13. NOTICES. All notices to be furnished pursuant to this Agreement shall be by email as follows: If to the Client: Matthew
Wolfson Email: CEO@electromed.com With a copy to: Eric P. Littman, Esquire Email: littmanlaw@gmail.com If to Consultant: Robert
Hymers Email: roberthymers@yahoo.com 14. Entire Agreement This agreement represents the entire understanding of the parties superseding
all prior agreements, understandings and discussions whether conveyed orally or in writing, and there are no other warranties,
commitments, understandings or representations with respect to this agreement. I represent that I have the authority to enter
into this agreement: Consultant x Name: Robert L Hymers Ill Client Name: Matthew Wolfson Title: President and CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]